Insights

Stay up to date on PsychoGenics’ latest research, press releases, and industry developments in preclinical drug discovery. Combine our expertise with yours to spark the translational power of your next CNS breakthrough.

POSTER

Functional, Sensorimotor, and Cognitive Outcomes Following Unilateral MCAO in Rats

June 24, 2026
Read More
POSTER

Behavioral and pharmacological characterization of the isosorbide dinitrate model of headache in male and female rats

June 15, 2026
Read More
POSTER

The NIH HEAL Initiative Preclinical Screening Platform for Pain Efforts to Validate Two Models of Chemotherapy-Induced Painful Neuropathy in the Rat

August 24, 2023
Read More
POSTER

Efforts to Accelerate Development of Non-Opioid, Non-Addictive Pain Therapeutics Within the NIH HEAL Initiative Preclinical Screening Platform for Pain and Validation Examples

August 24, 2023
Read More
POSTER

Characterization of the Rat MonoiodoacetateModel of Osteoarthritis: Evoked and Non-evoked Pain Response Assessments

August 24, 2023
Read More
POSTER

Characterization and optimization of rat models of osteoarthritis pain to profile novel assets in support of the NIH HEAL Initiative Preclinical Screening Platform for Pain (PSPP)

August 24, 2023
Read More
PUBLICATION

Immunotherapy Targeting the C-Terminal Domain of TDP-43 Decreases Neuropathology and Confers Neuroprotection in Mouse Models of ALS/FTD

February 20, 2023
Read More
PUBLICATION

The GBA1 D409V Mutation Exacerbates Synuclein Pathology to Differing Extents in two Alpha-Synuclein Models

August 24, 2022
Read More
PUBLICATION

Elevation of brain magnesium with Swiss chard and buckwheat extracts in an animal model of reduced magnesium dietary intake

November 4, 2021
Read More
WEBINAR

Molecular Biomarkers and Disease Markers at PsychoGenics [WEBINAR]

October 27, 2021
Read More
WEBINAR

Preclinical Seizure and Epilepsy [WEBINAR]

July 2, 2021
Read More